Adachi Y - Search Results

1

Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer.

Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M. Ono HA, et al. Among authors: adachi y. J Gastroenterol. 2005 Jan;40(1):31-42. doi: 10.1007/s00535-004-1490-y. J Gastroenterol. 2005. PMID: 15692787

2

Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.

Adachi Y, Matsubara S, Muramatsu T, Curiel DT, Reynolds PN. Adachi Y, et al. J Pediatr Surg. 2002 Apr;37(4):588-92. doi: 10.1053/jpsu.2002.31615. J Pediatr Surg. 2002. PMID: 11912516

3

Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.

Nagi P, Vickers SM, Davydova J, Adachi Y, Takayama K, Barker S, Krasnykh V, Curiel DT, Yamamoto M. Nagi P, et al. Among authors: adachi y. J Gastrointest Surg. 2003 Mar-Apr;7(3):364-71. doi: 10.1016/s1091-255x(02)00437-7. J Gastrointest Surg. 2003. PMID: 12654561

4

A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.

Takayama K, Reynolds PN, Short JJ, Kawakami Y, Adachi Y, Glasgow JN, Rots MG, Krasnykh V, Douglas JT, Curiel DT. Takayama K, et al. Among authors: adachi y. Virology. 2003 May 10;309(2):282-93. doi: 10.1016/s0042-6822(03)00067-9. Virology. 2003. PMID: 12758175 Free article.

5

Evaluation of tissue-specific promoters in carcinomas of the cervix uteri.

Rein DT, Breidenbach M, Nettelbeck DM, Kawakami Y, Siegal GP, Huh WK, Wang M, Hemminki A, Bauerschmitz GJ, Yamamoto M, Adachi Y, Takayama K, Dall P, Curiel DT. Rein DT, et al. Among authors: adachi y. J Gene Med. 2004 Nov;6(11):1281-9. doi: 10.1002/jgm.606. J Gene Med. 2004. PMID: 15368588

6

A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration.

Sekine S, Kataoka K, Fukuyama Y, Adachi Y, Davydova J, Yamamoto M, Kobayashi R, Fujihashi K, Suzuki H, Curiel DT, Shizukuishi S, McGhee JR, Fujihashi K. Sekine S, et al. Among authors: adachi y. J Immunol. 2008 Jun 15;180(12):8126-34. doi: 10.4049/jimmunol.180.12.8126. J Immunol. 2008. PMID: 18523277 Free PMC article.

7

Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.

Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT, Nishimoto N. Adachi Y, et al. Int J Cancer. 2006 Sep 15;119(6):1303-11. doi: 10.1002/ijc.22006. Int J Cancer. 2006. PMID: 16642474

8

Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor.

Yoshio-Hoshino N, Adachi Y, Aoki C, Pereboev A, Curiel DT, Nishimoto N. Yoshio-Hoshino N, et al. Among authors: adachi y. Cancer Res. 2007 Feb 1;67(3):871-5. doi: 10.1158/0008-5472.CAN-06-3641. Cancer Res. 2007. PMID: 17283116

9

VEGF targeting in mesotheliomas using an interleukin-6 signal inhibitor based on adenovirus gene delivery.

Adachi Y, Yoshio-Hoshino N, Aoki C, Nishimoto N. Adachi Y, et al. Anticancer Res. 2010 Jun;30(6):1947-52. Anticancer Res. 2010. PMID: 20651338

10

Gene therapy for multiple myeloma.

Adachi Y, Yoshio-Hoshino N, Nishimoto N. Adachi Y, et al. Curr Gene Ther. 2008 Aug;8(4):247-55. doi: 10.2174/156652308785160683. Curr Gene Ther. 2008. PMID: 18691020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,767 results

Search Page

Filters